↓ Skip to main content

Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

Overview of attention for article published in BMC Psychiatry, October 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
Published in
BMC Psychiatry, October 2020
DOI 10.1186/s12888-020-02867-8
Pubmed ID
Authors

Akira Iwanami, Kazuhiko Saito, Masakazu Fujiwara, Daiki Okutsu, Hironobu Ichikawa

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 12%
Other 7 10%
Student > Bachelor 7 10%
Researcher 5 7%
Student > Ph. D. Student 3 4%
Other 3 4%
Unknown 35 51%
Readers by discipline Count As %
Nursing and Health Professions 8 12%
Medicine and Dentistry 6 9%
Neuroscience 5 7%
Psychology 3 4%
Business, Management and Accounting 1 1%
Other 6 9%
Unknown 39 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2023.
All research outputs
#7,914,793
of 23,849,241 outputs
Outputs from BMC Psychiatry
#2,691
of 4,982 outputs
Outputs of similar age
#168,012
of 414,992 outputs
Outputs of similar age from BMC Psychiatry
#58
of 111 outputs
Altmetric has tracked 23,849,241 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,982 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.8. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 414,992 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.